Article

Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens.

Discipline of Gynecology, Escola Paulista de Medicina, São Paulo Hospital, Brazil.
International Journal of Gynecology & Obstetrics (Impact Factor: 1.84). 05/1995; 49(2):165-9. DOI: 10.1016/0020-7292(95)02358-J
Source: PubMed

ABSTRACT The aim of the study was to investigate clinically and urodynamically the effects of hormonal replacement in the treatment of genuine stress urinary incontinence in postmenopausal females.
Clinical and urodynamic variables of 30 postmenopausal women with genuine stress urinary incontinence were evaluated after 3 months' treatment with conjugated estrogens plus progestogens. Urodynamic evaluations were performed in all patients before and after treatment.
Forty-six percent of the patients treated medically were judged to be cured and 43% were judged to be markedly improved. Maximum urethral closure pressure, maximum cystometric capacity and mean flow were significantly increased. Residual urine and diurnal and nocturnal voluntary micturition were markedly decreased (P < 0.05).
We conclude that hormone replacement in the form of conjugated estrogens plus progestogens results in the clinical and urodynamic improvement of genuine stress urinary incontinence in postmenopausal women.

0 Bookmarks
 · 
62 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The decline in sex hormone levels that accompanies the menopause has substantial effects on the tissues of the urogenital system, leading to atrophic changes. These changes can have negative effects on sexual and urinary function. The authors evaluate the repercussion of hypoestrogenism and sexual steroids on some elements of the pelvic floor and lower urinary tract. They summarize their research work and review significant published papers. They emphasize the changes in urinary mucosae, periurethral vessels, muscular layer, connective tissue, gene expression, autonomic nervous system receptors, as well as the main clinical aspects involved.
    Climacteric 02/2011; 14(1):5-14. · 1.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of the present study was to assess the effect of tamoxifen on periurethral vessels by Doppler velocimetry examination. Increase in the number of these vessels as well as decrease in resistance and pulsatility indices by tamoxifen were observed.
    International Urogynecology Journal 01/2005; 16(1):56-9; discussion 59. · 2.17 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objetivo: avaliar os efeitos do uso de corticóides sobre os vasos e o epitélio da bexiga e da uretra de ratas. Método: utilizaram-se 54 ratas, divididas em 5 grupos: Grupo I - dez ratas castradas; Grupo II - onze ratas castradas que receberam succinato sódico de prednisolona, na dose de 15 mg/kg de peso, por via intraperitoneal durante 26 dias; Grupo III - doze ratas castradas que receberam o mesmo corticosteróide, na mesma dose associado ao 17 beta-estradiol na dose de 10 mg/kg, subcutâneo, nos últimos 5 dias antes de serem sacrificadas; Grupo IV - onze ratas castradas que receberam placebo por 26 dias; Grupo V - dez ratas não-castradas que receberam o mesmo corticosteróide, na dose e duração do grupo II. Resultados: observou-se na bexiga do grupo castrado que recebeu corticosteróide uma média de 1,8 vasos, número semelhante ao que recebeu corticosteróide e estrogênio, contra 0,8 vasos no grupo com placebo. Já na uretra, identificaram-se 0,7 vaso no grupo com corticosteróide, contra 0,9 vaso do grupo com corticosteróide associado ao estrogênio e 0,4 vaso no grupo placebo. Quanto à mucosa, observou-se que a espessura do epitélio vesical passou de 14,1 mm do grupo placebo para 20,6 mm no que recebeu corticosteróide e para 22,6 mm com corticosteróide e estrogênio. Da mesma maneira, a espessura do epitélio uretral passou de 12,4 mm no grupo controle para 15,1 mm no grupo com corticosteróide e para 16,7 mm com corticosteróide e estrogênio. Conclusões: a prednisolona, na dose e na duração utilizadas, aumentaram o número de vasos e a espessura do epitélio da bexiga e da uretra.
    Revista Brasileira de Ginecologia e Obstetrícia. 01/2000;